Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptors factor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
Most Relevant Literature
- Long Noncoding RNA LIFR-AS1: A New Player in Human Cancers.
- Type H vessel/platelet-derived growth factor receptor β+ perivascular cell disintegration is involve…
- CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand B…
- Transforming growth factor beta receptor 2 (Tgfbr2) deficiency in keratocytes results in corneal ect…
- Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor rece…
Most Relevant Clinical Trials
- A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene A…
- A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive…
- Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lun…
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth…
- A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With A…
